🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Aileron Therapeutics Inc (ALRN)

NASDAQ
Currency in USD
4.0000
0.0000(0.00%)
Closed
After Hours
4.00000.0000(0.00%)
ALRN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
3.92504.1500
52 wk Range
1.33527.4200
Prev. Close
4
Open
4
Day's Range
3.925-4.15
52 wk Range
1.3352-7.42
Volume
105,876
Average Vol. (3m)
75,044
1-Year Change
244.83%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ALRN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
13.0000
Upside
+225.0000%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Aileron Therapeutics Inc Company Profile

Aileron Therapeutics, Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company’s lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate is LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company’s pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is headquartered in Austin, Texas.

Compare ALRN to Peers and Sector

Metrics to compare
ALRN
Peers
Sector
Relationship
P/E Ratio
−3.4x−4.8x−0.6x
PEG Ratio
−0.11−0.140.00
Price / Book
1.5x3.2x2.6x
Price / LTM Sales
-106.0x3.2x
Upside (Analyst Target)
225.0%109.8%47.5%
Fair Value Upside
Unlock−8.8%6.7%Unlock

People Also Watch

19.960
SMMT
+5.11%
2.620
SPWH
+0.77%
5.0100
PRTG
-10.22%
16.960
MNPR
+15.93%
3.8900
RMTI
+2.64%

FAQ

What Is the Aileron Therapeutics (ALRN) Stock Price Today?

The Aileron Therapeutics stock price today is 4.00

What Stock Exchange Does Aileron Therapeutics Trade On?

Aileron Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Aileron Therapeutics?

The stock symbol for Aileron Therapeutics is "ALRN."

What Is the Aileron Therapeutics Market Cap?

As of today, Aileron Therapeutics market cap is 86.66M.

What is Aileron Therapeutics Earnings Per Share?

The Aileron Therapeutics EPS is -2.68.

From a Technical Analysis Perspective, Is ALRN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.